Fragment-based drug design : (notice n° 28680)
000 -LEADER | |
---|---|
fixed length control field | 05828cam a2200733Ki 4500 |
001 - CONTROL NUMBER | |
control field | ocn746854847 |
003 - CONTROL NUMBER IDENTIFIER | |
control field | OCoLC |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20211202100619.0 |
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION | |
fixed length control field | m o d |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
fixed length control field | cr cnu---unuuu |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 110816s2011 ne af ob 001 0 eng d |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | N$T |
Language of cataloging | eng |
Transcribing agency | N$T |
Modifying agency | BUF |
-- | UMC |
-- | SCB |
-- | E7B |
-- | OCLCQ |
-- | UKMGB |
-- | OCLCQ |
-- | YDXCP |
-- | OPELS |
-- | OCLCQ |
-- | OPELS |
-- | OCLCF |
Description conventions | rda |
016 7# - NATIONAL BIBLIOGRAPHIC AGENCY CONTROL NUMBER | |
Record control number | 015705653 |
Source | Uk |
019 ## - | |
-- | 709639496 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 9780123812759 (electronic bk.) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 0123812755 (electronic bk.) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 9780123812742 (electronic bk.) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 0123812747 (electronic bk.) |
029 1# - (OCLC) | |
-- | AU@ |
-- | 000046885105 |
035 ## - SYSTEM CONTROL NUMBER | |
System control number | (OCoLC)746854847 |
Canceled/invalid control number | (OCoLC)709639496 |
050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
Classification number | QP601 |
Item number | .M49eb vol. 493 |
072 #7 - SUBJECT CATEGORY CODE | |
Subject category code | MED |
Subject category code subdivision | 023000 |
Source | bisacsh |
072 #7 - SUBJECT CATEGORY CODE | |
Subject category code | MED |
Subject category code subdivision | 071000 |
Source | bisacsh |
072 #7 - SUBJECT CATEGORY CODE | |
Subject category code | MED |
Subject category code subdivision | 072000 |
Source | bisacsh |
072 #7 - SUBJECT CATEGORY CODE | |
Subject category code | MED |
Subject category code subdivision | 058170 |
Source | bisacsh |
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER | |
Classification number | 615.19 |
Edition number | 23 |
049 ## - LOCAL HOLDINGS (OCLC) | |
Holding library | TEFA |
245 00 - TITLE STATEMENT | |
Title | Fragment-based drug design : |
Remainder of title | tools, practical approaches, and examples / |
Statement of responsibility, etc | edited by Lawrence C. Kuo. |
250 ## - EDITION STATEMENT | |
Edition statement | 1st ed. |
264 #1 - | |
-- | Amsterdam ; |
-- | Boston, Mass. : |
-- | Academic Press. |
264 #4 - | |
-- | c2011. |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 1 online resource (li, 591 pages, [16] pages of plates) : |
Other physical details | illustrations (some color) |
336 ## - CONTENT TYPE | |
Content Type Term | text |
Content Type Code | txt |
Source | rdacontent |
337 ## - MEDIA TYPE | |
Media Type Term | computer |
Media Type Code | c |
Source | rdamedia |
338 ## - CARRIER TYPE | |
Carrier Type Term | online resource |
Carrier Type Code | cr |
Source | rdacarrier |
347 ## - | |
-- | data file |
-- | rda |
380 ## - | |
-- | Bibliography |
490 1# - SERIES STATEMENT | |
Series statement | Methods in enzymology ; |
Volume number/sequential designation | v. 493 |
504 ## - BIBLIOGRAPHY, ETC. NOTE | |
Bibliography, etc | Includes bibliographical references and indexes. |
505 0# - FORMATTED CONTENTS NOTE | |
Formatted contents note | Designing a diverse high-quality library for crystallography-based FBDD screening -- Preparation of protein samples for NMR structure, function, and small-molecule screening studies -- Key factors for successful generation of protein-fragment structures requirement on protein, crystals, and technology -- Predicting the success of fragment screening by X-ray crystallography -- Fragment screening of stabilized G-protein-coupled receptors using biophysical methods -- Using computational techniques in fragment-based drug discovery -- How to avoid rediscovering the known -- From experimental design to validated hits a comprehensive walk-through of fragment lead identification using surface plasmon resonance -- Practical aspects of NMR-based fragment screening -- Binding site identification and structure determination of protein-ligand complexes by NMR a semiautomated approach -- Protein thermal shifts to identify low molecular weight fragments -- HTS reporter displacement assay for fragment screening and fragment evolution toward leads with optimized binding kinetics, binding selectivity, and thermodynamic signature -- Fragment screening purely with protein crystallography -- Computational approach to de novo discovery of fragment binding for novel protein states -- Lead generation and examples opinion regarding how to follow up hits -- Medicinal chemistry inspired fragment-based drug discovery -- Effective progression of nuclear magnetic resonance-detected fragment hits -- Advancing fragment binders to lead-like compounds using ligand and protein-based NMR spectroscopy -- Electron density guided fragment-based drug design--a lead generation example -- Experiences in fragment-based lead discovery -- Fragment screening of infectious disease targets in a structural genomics environment. |
588 ## - | |
-- | Description based on print version record. |
520 ## - SUMMARY, ETC. | |
Summary, etc | There are numerous excellent reviews on Fragment Based Drug Discovery (FBDD), but there are to date no hand-holding guides or protocols with which one can embark on this orthogonal approach to complement traditional high throughput screening methodologies. This Methods in Enzymology volume offers the tools, practical approaches, and hit-to-lead examples on how to conduct FBDD screens. The chapters in this volume cover methods that have proven to be successful in generating leads from fragments, including chapters on how to apply computational techniques, nuclear magnetic resonance, surface plasma resonance, thermal shift and binding assays, protein crystallography, and medicinal chemistry in FBDD. Also elaborated by experienced researchers in FBDD are sample preparations of fragments, proteins, and GPCR as well as examples of how to generate leads from hits. Offers the tools, practical approaches, and hit-to-lead examples on how to conduct FBDD screens. The chapters in this volume cover methods that have proven to be successful in generating leads from fragments, including chapters on how to apply computational techniques, nuclear magnetic resonance, surface plasma resonance, thermal shift and binding assays, protein crystallography, and medicinal chemistry in FBDD. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Drugs |
General subdivision | Design. |
9 (RLIN) | 40331 |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Drug development. |
9 (RLIN) | 40332 |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Drugs |
General subdivision | Research. |
9 (RLIN) | 40333 |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | MEDICAL |
General subdivision | Drug Guides. |
Source of heading or term | bisacsh |
9 (RLIN) | 40334 |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | MEDICAL |
General subdivision | Pharmacology. |
Source of heading or term | bisacsh |
9 (RLIN) | 40335 |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | MEDICAL |
General subdivision | Pharmacy. |
Source of heading or term | bisacsh |
9 (RLIN) | 40336 |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | MEDICAL |
General subdivision | Nursing |
-- | Pharmacology. |
Source of heading or term | bisacsh |
9 (RLIN) | 40337 |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Drug development. |
Source of heading or term | fast |
-- | (OCoLC)fst00898670 |
9 (RLIN) | 40332 |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Drugs |
General subdivision | Design. |
Source of heading or term | fast |
-- | (OCoLC)fst00898790 |
9 (RLIN) | 40331 |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Drugs |
General subdivision | Research. |
Source of heading or term | fast |
-- | (OCoLC)fst00898894 |
9 (RLIN) | 40333 |
655 #4 - INDEX TERM--GENRE/FORM | |
Genre/form data or focus term | Electronic books. |
9 (RLIN) | 20 |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Kuo, Lawrence C. |
9 (RLIN) | 40338 |
776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
Display text | Print version: |
Title | Fragment-based drug design. |
Edition | 1st ed. |
Place, publisher, and date of publication | Amsterdam ; Boston, Mass. : Academic Press, c2011 |
International Standard Book Number | 9780123812742 |
Record control number | (OCoLC)707096179 |
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE | |
Uniform title | Methods in enzymology ; |
Volume number/sequential designation | v. 493. |
9 (RLIN) | 26980 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="http://www.sciencedirect.com/science/book/9780123812742">http://www.sciencedirect.com/science/book/9780123812742</a> |
938 ## - | |
-- | ebrary |
-- | EBRY |
-- | ebr10483474 |
938 ## - | |
-- | YBP Library Services |
-- | YANK |
-- | 6987015 |
938 ## - | |
-- | EBSCOhost |
-- | EBSC |
-- | 376907 |
942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
Koha item type | Ebook |
956 ## - LOCAL ELECTRONIC LOCATION AND ACCESS (OCLC) | |
Electronic name | Consortium |
994 ## - | |
-- | C0 |
-- | TEF |
Pas d'exemplaire disponible.